Methods compositions, and kits for detection of microRNA

• US 8,314,220 B2
• Filed: 01/26/2007
• Issued: 11/20/2012
• Est. Priority Date: 01/26/2007
• Status: Active Grant

• Current Assignee: Agilent Technologies, Inc.
• Original Assignee: Agilent Technologies, Inc.
• Inventors: Mullinax, Rebecca L., Sorge, Joseph A.
• Primary Examiner(s): Chunduru, Prabha
• Application Number:
  US11/627,926
• Publication Number:
  US 20080182239A1
• Time in Patent Office: 2,125 Days
• Field of Search: 536/22.1, 435/6
• US Class Current: 536/22.1
• CPC Class Codes: C12Q 1/6811 Selection methods for production or design of target specific oligonucleotides or binding molecules
• CPC Class Codes: C12Q 1/6844 Nucleic acid amplification reactions
• CPC Class Codes: C12Q 1/6858 Allele-specific amplification
• CPC Class Codes: C12Q 2525/207 siRNA, miRNA
• CPC Class Codes: Y10T 436/143333 Saccharide [e.g., DNA, etc.]

Abstract

The present invention provides methods, nucleic acids, compositions, and kits for detecting microRNA (miRNA) in samples. The methods comprise designing mRNA-specific primers, adding a polyA tail to the miRNA, and using reverse transcription and amplification to detect the miRNA. The nucleic acids, compositions, and kits typically comprise some or all of the components necessary to practice the methods of the invention.

Claims

1. A method of designing and making a nucleotide primer for an miRNA, said method comprising:

comparing two or more nucleotide sequences of miRNA having a region of identity or homology;

identifying one or more nucleotide positions with heterogeneity among the sequences compared;

selecting a nucleotide at or within two nucleotides of the identified heterogeneous positions as the 3′

end of the primer, wherein the selected nucleotide is, part of the natural sequence of an miRNA of interest among the sequences compared but is not the natural 3′

terminal nucleotide of the miRNA;

selecting some or all of the nucleotides of the remaining region of identity or homology as additional nucleotides of the primer;

adding zero to ten nucleotides to the 5′

end of the primer; and

synthesizing the primer.

2. The method of claim 1, wherein zero to three guanine nucleotides are added to the 5′

end of the primer.

3. The method of claim 1, wherein the Tm of the designed primer is from about 45 degrees to about 70 degrees Celsius.

4. The method of claim 1, wherein the nucleotide sequences are selected from noncoding RNA sequences.

5. The method of claim 1, wherein the nucleotide sequences are selected from miRNA sequences.

6. The method of claim 1, wherein the 3′

end of the primer is selected to be at a heterogeneous nucleotide position.

7. A composition comprising the primer of claim 1.

8. The composition of claim 7, comprising at least one reverse transcriptase, at least one adapter primer, at least one reverse amplification primer, at least one polymerase, or a combination of two or more of these.

9. The composition of claim 7, comprising a sample containing or suspected of containing a miRNA of interest.

10. The composition of claim 7, comprising some or all of the components necessary to perform QPCR.

11. A kit comprising, in packaged combination, at least one miRNA-specific primer comprising a nucleotide at the 3′

end that is heterogeneous among at least three miRNA species, and comprising at least one guanine nucleotide on the 5′

end that is not found naturally in the target miRNA, wherein the nucleotide at the 3′

end of the primer is part of the natural sequence of the target miRNA but is not the natural 3′

terminal nucleotide of the miRNA.

12. The kit of claim 11, comprising at least one reverse transcriptase, at least one adapter primer, at least one reverse amplification primer, at least one polymerase, or a combination of two or more of these.

13. The kit of claim 11, comprising a sample containing or suspected of containing a miRNA of interest.